Compare, Analyse with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   MYLAN
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
MYLAN
Dec-18
ALKEM LABORATORIES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,5893,390-   
Low Rs1,2321,866-   
Sales per share (Unadj.) Rs417.51,559.9-  
Earnings per share (Unadj.) Rs56.342.4-  
Cash flow per share (Unadj.) Rs64.7334.4-  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.91,687.5-  
Shares outstanding (eoy) m119.57514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.7 200.6%   
Avg P/E ratio x25.162.0 40.4%  
P/CF ratio (eoy) x21.87.9 277.4%  
Price / Book Value ratio x4.81.6 309.2%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,6531,352,115 12.5%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m9,1710-   
Avg. sales/employee Rs ThNM22,930.8-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM622.7-  
INCOME DATA
Net Sales Rs m49,915802,578 6.2%  
Other income Rs m1,6450-   
Total revenues Rs m51,561802,578 6.4%   
Gross profit Rs m8,482207,678 4.1%  
Depreciation Rs m1,006150,274 0.7%   
Interest Rs m67138,601 1.7%   
Profit before tax Rs m8,45118,802 44.9%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606-2,991 -53.7%   
Profit after tax Rs m6,73121,793 30.9%  
Gross profit margin %17.025.9 65.7%  
Effective tax rate %19.0-15.9 -119.5%   
Net profit margin %13.52.7 496.6%  
BALANCE SHEET DATA
Current assets Rs m27,062448,159 6.0%   
Current liabilities Rs m15,324326,757 4.7%   
Net working cap to sales %23.515.1 155.5%  
Current ratio x1.81.4 128.8%  
Inventory Days Days6784 79.6%  
Debtors Days Days4193 44.2%  
Net fixed assets Rs m12,610155,687 8.1%   
Share capital Rs m239427 56.0%   
"Free" reserves Rs m34,4900-   
Net worth Rs m35,027868,243 4.0%   
Long term debt Rs m1,212937,113 0.1%   
Total assets Rs m54,3872,328,965 2.3%  
Interest coverage x13.61.5 914.7%   
Debt to equity ratio x01.1 3.2%  
Sales to assets ratio x0.90.3 266.3%   
Return on assets %13.62.6 524.8%  
Return on equity %19.22.5 765.6%  
Return on capital %24.93.2 781.8%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Net fx Rs m3,5520-   
CASH FLOW
From Operations Rs m7,259166,776 4.4%  
From Investments Rs m1,864-86,205 -2.2%  
From Financial Activity Rs m-9,273-77,694 11.9%  
Net Cashflow Rs m-1501,382 -10.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.22 Rs / USD

Compare ALKEM LABORATORIES With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ALKEM LABORATORIES With: SHASUN PHARMA  NATCO PHARMA  GSK PHARMA  PFIZER  TTK HEALTHCARE  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Oct 18, 2019 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS